5 - 8 of 132 news items
The Royal Brompton Cystic Fibrosis (CF) Clinical Trials team celebrated three well-deserved wins at the North West London Clinical Research Awards, where they were recognised for their outstanding work carrying out ground-breaking CF research.
A new multi-million pound EU-funded research project could help NHS staff provide life-saving treatment to some of the country’s most ill patients.
NHS England has today announced that they have agreed to fund the precision medicines Orkambi and Symkevi for people with cystic fibrosis (CF). These medicines have been shown to slow the decline in lung function and reduce hospital admissions.
A public event to ‘demystify’ what goes on in a specialist heart hospital attracted more than 160 staff, patients and members of the public, including over a hundred students from local schools, keen to improve their resuscitation skills.